Laboratory Abnormalities in Cholestasis
The hallmark laboratory abnormalities in cholestasis are elevated serum alkaline phosphatase (AP) and gamma-glutamyltransferase (GGT), followed by conjugated hyperbilirubinemia in more advanced disease. 1
Early Biochemical Markers
The earliest laboratory changes in cholestasis, often appearing before any clinical symptoms, include:
- Alkaline phosphatase (AP): Elevated, typically >1.5 times the upper limit of normal (ULN)
- Gamma-glutamyltransferase (GGT): Elevated, typically >3 times ULN
- These elevations occur before jaundice develops and may be detected in completely asymptomatic patients 1
The pattern is distinctly cholestatic when AP and GGT elevations exceed those of aminotransferases (ALT/AST). 2
Advanced Stage Markers
As cholestasis progresses:
- Conjugated (direct) bilirubin: Becomes elevated, leading to clinical jaundice
- The majority of measurable bilirubin should be conjugated in cholestasis (except in Gilbert's syndrome where unconjugated predominates) 3
- Aminotransferases (ALT/AST): May be elevated but typically less prominently than AP and GGT 4
Important Diagnostic Caveats
Isolated GGT Elevation
Isolated serum GGT elevation has little specificity for cholestasis and may result from:
- Alcohol consumption
- Drug-induced enzyme induction
- Therefore, GGT should not be used alone to diagnose cholestasis 1
Isolated AP Elevation
Isolated AP elevation can occur from non-hepatic sources:
- Rapid bone growth (children/adolescents)
- Bone disease (Paget's disease)
- Pregnancy
- Measure GGT to confirm hepatic origin of elevated AP 3
Rare Cholestatic Disorders
Some rare conditions (progressive familial intrahepatic cholestasis types 1 & 2, bile acid synthesis defects) may present with isolated AP elevation 1
Markers of Disease Severity
In chronic or severe cholestasis, additional abnormalities develop:
- Prothrombin time (PT)/INR: Prolonged due to vitamin K malabsorption or reduced synthetic function (requires >70% loss of function) 3
- Albumin: May be reduced, though this is non-specific and occurs in many conditions beyond liver disease 3
- Platelets: Thrombocytopenia indicates advanced disease with portal hypertension 3
Diagnostic Thresholds
The proposed cut-off levels requiring diagnostic work-up are:
- AP >1.5 times ULN
- GGT >3 times ULN 1
These thresholds help distinguish clinically significant cholestasis from minor laboratory variations and guide the need for further investigation to differentiate intrahepatic from extrahepatic causes.